Status:

COMPLETED

Treatment of Interproximal Cavities on Primary Molar Teeth With Silver Diamine Fluoride

Lead Sponsor:

Children's Hospital Los Angeles

Collaborating Sponsors:

University of Southern California

Conditions:

Dental Caries in Children

Dental Caries Class II

Eligibility:

All Genders

3-12 years

Phase:

NA

Brief Summary

This study investigates whether 1) Silver diamine fluoride (SDF) application using Super Floss can arrest and/or reverse initial interproximal caries on primary molars and 2) whether SDF applied with ...

Detailed Description

Interproximal carious lesions are challenging to control and arrest due to difficulty reaching the contact area (in between teeth), limited salivary access, and poor flossing compliance in children an...

Eligibility Criteria

Inclusion

  • ASA I and ASA II children, aged 3-12
  • Behavior of 3 or 4 on Frankl scale
  • Radiographic decay within enamel or extending to the dentin-enamel junction based on International Caries Classification and Management System (ICCMS) Categories 1, 2 and 3 "Initial stages".
  • Target interproximal lesion does not have existing restoration, recurrent decay, or adjacent teeth with existing restorations.

Exclusion

  • Children who are not ASA I or ASA II
  • Children who are allergic to or intolerant of SDF
  • Children who have known sensitivity to silver or heavy metal-ions, or have abnormal skin sensitization.
  • Children who have ulcerative gingivitis or stomatitis.
  • Carious interproximal lesions on primary molars in ICCMS Category 4, 5, or 6 18 , which signify the extent of the carious lesion radiographically reaching the middle 1/3 of dentin, inner 1/3 of dentin, and into the pulp respectively.
  • Behavior of a child within the Frankl 1 or 2 category, indicating a "Definitely Negative" and "Negative" behavior, which may compromise safe application of SDF.

Key Trial Info

Start Date :

January 22 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 31 2023

Estimated Enrollment :

51 Patients enrolled

Trial Details

Trial ID

NCT03770286

Start Date

January 22 2019

End Date

May 31 2023

Last Update

October 15 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Childrens Hospital Los Angeles

Los Angeles, California, United States, 90027